The psychosis analysis in real-world on a cohort of large-scale patients with schizophrenia
暂无分享,去创建一个
Heng Weng | Tianyong Hao | Aihua Ou | Wenyan Tan | Haicheng Lin | Baoxin Lei | Zehui He | Ning Yang | Fujun Jia | A. Ou | Tianyong Hao | F. Jia | Heng Weng | Zehui He | Wenyan Tan | Haicheng Lin | Ning Yang | Baoxin Lei
[1] Hong Wang,et al. The China Mental Health Survey: II. Design and field procedures , 2016, Social Psychiatry and Psychiatric Epidemiology.
[2] J. Zhai,et al. An investigation of economic costs of schizophrenia in two areas of China , 2013, International Journal of Mental Health Systems.
[3] Peter B. Jones,et al. Association of Environment With the Risk of Developing Psychotic Disorders in Rural Populations , 2017, JAMA psychiatry.
[4] Keyong Dong,et al. Medical insurance system evolution in China , 2009 .
[5] Peter B. Jones,et al. International incidence of psychotic disorders, 2002–17: a systematic review and meta-analysis , 2019, The Lancet. Public health.
[6] C. Pantelis,et al. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis , 2016, Neuroscience & Biobehavioral Reviews.
[7] Bao-yun Liang,et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys , 2014, Acta psychiatrica Scandinavica.
[8] J. Li,et al. The family economic status and outcome of people with schizophrenia in Xinjin, Chengdu, China: 14-year follow-up study , 2017, The International journal of social psychiatry.
[9] Guoqin Zhang,et al. Urbanization and health in China, thinking at the national, local and individual levels , 2016, Environmental Health.
[10] A. Furnham,et al. Awareness of schizophrenia and intellectual disability and stigma across ethnic groups in the UK , 2013, Psychiatry Research.
[11] James G. Scott,et al. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016 , 2018, Schizophrenia bulletin.
[12] Qichang Shi,et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey , 2009, The Lancet.
[13] M. De Hert,et al. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review , 2013, Therapeutic advances in psychopharmacology.
[14] T. B. Üstün,et al. Age of onset of mental disorders: a review of recent literature , 2007, Current opinion in psychiatry.
[15] V. Janout,et al. Epidemiology and risk factors of schizophrenia. , 2016, Neuro endocrinology letters.
[16] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[17] E. Theodoratou,et al. Causes of accidental childhood deaths in China in 2010: A systematic review and analysis , 2015, Journal of global health.
[18] Wei Wang,et al. Online Supplementary Document , 2014 .
[19] Jayashri Kulkarni,et al. Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review , 2012, Schizophrenia research and treatment.
[20] Hong Wang,et al. The China Mental Health Survey (CMHS): I. background, aims and measures , 2016, Social Psychiatry and Psychiatric Epidemiology.
[21] S. Saha,et al. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? , 2007, Archives of general psychiatry.
[22] P. Mortensen,et al. Parental socio-economic status and risk of first admission with schizophrenia , 2004, Social Psychiatry and Psychiatric Epidemiology.
[23] P. Mortensen,et al. Parental socio-economic status and risk of first admission with schizophrenia , 2004, Social psychiatry and psychiatric epidemiology.
[24] E. Susser,et al. New directions in the epidemiology of schizophrenia , 2009, The Medical journal of Australia.
[25] R. Kessler,et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China , 2005, Psychological Medicine.
[26] Xin Yu,et al. Mental health system in China: history, recent service reform and future challenges , 2011, World psychiatry : official journal of the World Psychiatric Association.
[27] R. Kahn,et al. Sex differences in the risk of schizophrenia: evidence from meta-analysis. , 2003, Archives of general psychiatry.
[28] S. Potkin,et al. Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia , 2015, Schizophrenia Research.
[29] J. Mcgrath. The surprisingly rich contours of schizophrenia epidemiology. , 2007, Archives of general psychiatry.
[30] H. Whiteford,et al. Pragmatic Psychiatric Epidemiology—If You Can’t Count It, It Won’t Count , 2018, JAMA psychiatry.
[31] A. Jablensky,et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders , 2016, The Australian and New Zealand journal of psychiatry.
[32] T. Vos,et al. Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010 , 2014, Epidemiology and Psychiatric Sciences.
[33] H. Inskip,et al. Twenty-five year mortality of a community cohort with schizophrenia , 2010, British Journal of Psychiatry.
[34] T. Hu. Perspectives: an international review of the national cost estimates of mental illness, 1990-2003. , 2006, The journal of mental health policy and economics.
[35] B. Macmahon,et al. Epidemiology: Principles and Methods , 1970 .
[36] Peter B. Jones,et al. The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study. , 2017, The American journal of psychiatry.
[37] Diana O Perkins,et al. Predictors of noncompliance in patients with schizophrenia. , 2002, The Journal of clinical psychiatry.
[38] Tao Li,et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. , 2019, The lancet. Psychiatry.
[39] C. Weijer,et al. Helsinki discords: FDA, ethics, and international drug trials , 2009, The Lancet.
[40] R. Kessler,et al. Impaired Role Functioning and Treatment Rates for Mental Disorders and Chronic Physical Disorders in Metropolitan China , 2009, Psychosomatic medicine.
[41] T. Treuer,et al. The personal, societal, and economic burden of schizophrenia in the People’s Republic of China: implications for antipsychotic therapy , 2013, ClinicoEconomics and outcomes research : CEOR.